Brief: China Shineway Pharmaceutical Says Liu Tiejun Appointed As Executive Director
31/10/2022 04:04
Oct 31 (Reuters) - China Shineway Pharmaceutical Group
Ltd 2877.HK :
* LIU TIEJUN HAS BEEN APPOINTED AS EXECUTIVE DIRECTOR
* CHEN ZHONG TENDERED HIS RESIGNATION AS AN EXECUTIVE
DIRECTOR
Further company coverage: 2877.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Shineway Pharmaceutical
See all newsBrief: China Shineway Pharmaceutical Posts Q1 Turnover Of RMB624 MLN
Brief: China Shineway Pharmaceutical Declares 2026 First Interim Dividend RMB43 Cents Per Share
Brief: China Shineway Pharmaceutical Group FY Net Income RMB 840 Million
Brief: China Shineway Pharmaceutical Posts Nine Months Turnover RMB2,887 Mln
Brief: China Shineway Pharmaceutical Group Posts H1 Net Income RMB 626.5 Mln